NCT07649031 MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
| NCT ID | NCT07649031 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Fanconi Anemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-06-23 |
| Primary Completion | 2030-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2026-06-23 with a primary completion date of 2030-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.
Eligibility Criteria
Inclusion Criteria: * Patients with a diagnosis of Fanconi Anemia who are willing to participate and willing to have MRIs * Willing to provide informed consent Exclusion Criteria: * Patient without diagnosis of FA * Patients with FA who are under the age of 18 * Unable to tolerate any MRI due to claustrophobia * Any contraindication for the MRI * Unable to provide informed consent or comply with the study protocol
Contact & Investigator
Rachel Uppgaard
PRINCIPAL INVESTIGATOR
University of Minnesota
Frequently Asked Questions
Who can join the NCT07649031 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Fanconi Anemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07649031 currently recruiting?
Yes, NCT07649031 is actively recruiting participants. Contact the research team at camp2757@umn.edu for enrollment information.
Where is the NCT07649031 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT07649031 clinical trial?
NCT07649031 is sponsored by University of Minnesota. The principal investigator is Rachel Uppgaard at University of Minnesota. The trial plans to enroll 80 participants.